TG Therapeutics | TGTX - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
AbbVie USD 3.58B 316M 2026-03
Alaunos Therapeutics USD 447K 138K 2026-03
Amgen USD 1.58B 354M 2026-03
Ardelyx USD 75.92M 7.69M 2025-12
Arrowhead Research USD 41.74M 4.28M 2026-03
Bayer EUR 3.7B 356M 2026-03
Biogen USD 554.3M 128.2M 2026-03
Corcept Therapeutics USD 128.04M 13.3M 2026-03
Curis USD 1.34M 3.45M 2025-12
Gilead Sciences USD 1.45B 326M 2026-03
J&J USD 6.03B 719M 2026-03
Karyopharm Therapeutics USD 9.56M 17.63M 2025-12
Novartis USD 3.14B 296M 2026-03
Novavax USD 25.53M 1.34M 2025-12
PTC Therapeutics USD 73.89M 13.31M 2026-03
Puma Biotechnology USD 16.82M 8.15M 2024-09
Regeneron Pharmaceuticals USD 647.7M 127.3M 2026-03
Roche Holding CHF 7.28B 3.99B 2025-12
TG Therapeutics USD 73.14M 22.42M 2026-03
Verastem USD 24.44M 12.17M 2025-12
Vertex Pharmaceuticals USD 493.7M 6.7M 2026-03